What the latest DEA Proposed Rule Means for Telemedicine Prescribing of Controlled Substances – Nixon Gwilt Law
Late last Friday, the US Drug Enforcement Agency (DEA) released a proposed rule to make permanent some of the flexibilities allowed during the Public Health Emergency (PHE) for telemedicine companies whose providers prescribe controlled substances. In a recent post, our friends at Nixon Gwilt Law Group share updates on: What these proposed changes are; How […]